These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 37919650)

  • 1. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 3. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
    He X; Huang X; Qian Y; Sun T
    Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
    Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
    Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A; Şahin M; Kandemir İ; Bulakçı B; Aksakal MT; Karapınar E; Sever H; Baş F
    Lipids Health Dis; 2024 Jul; 23(1):208. PubMed ID: 38956572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Trochimczyk K; Flisiak-Jackiewicz M; Bobrus-Chociej A; Lebensztejn A; Wojtkowska M; Jamiołkowski J; Lebensztejn DM
    Med Sci Monit; 2024 Jul; 30():e943375. PubMed ID: 38956840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
    Zeng P; Cai X; Yu X; Gong L
    Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Associations Between Insulin Resistance Indexes and Hyperuricemia in Hypertensive Population].
    Xiong F; Yu C; Zhu LJ; Wang T; Zhou W; Bao HH; Cheng XS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):390-398. PubMed ID: 37407524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.
    Chen Q; Hu P; Hou X; Sun Y; Jiao M; Peng L; Dai Z; Yin X; Liu R; Li Y; Zhu C
    Cardiovasc Diabetol; 2024 Jul; 23(1):232. PubMed ID: 38965572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between triglyceride glucose index-related indices with gallstone disease among US adults.
    Fu C; Li X; Wang Y; Chen J; Yang Y; Liu K
    Lipids Health Dis; 2024 Jun; 23(1):203. PubMed ID: 38937793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].
    Xiao J; Li Y; Fang M; Gong H; Li W; Zhang C; Chen F; Zhang Y; Han T
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1266-1271. PubMed ID: 39051072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK; Shin SR
    Metab Syndr Relat Disord; 2024 Jun; 22(5):402-409. PubMed ID: 38574322
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
    BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study.
    Sun J; Yan C; Wen J; Wang F; Wu H; Xu F
    BMC Gastroenterol; 2024 Jul; 24(1):221. PubMed ID: 38987694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
    Dong C; Zhang CR; Xue BY; Miu WF; Fang NY; Li K; Ou ZJ; Xu YQ
    Zhongguo Zhen Jiu; 2020 Feb; 40(2):129-34. PubMed ID: 32100496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
    Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.